PTEN and cancer: During the comprehensive analysis including all cancer types, the chi‐square test did not demonstrate a significant difference in the prevalence of PTEN mutations between patients with a single PIK3CA mutation (36 of 425 cases) and those with multiple PIK3CA mutations (6 of 49 cases).